longbridge

Karyopharm Therap

KPTI
----

All Shareholders

Shareholder Type

  • Institutions82.32%
  • VC/PE firms8.29%
  • Hedge funds6.58%
  • Individuals & Insiders2.80%
  • Private companies<0.01%

Major Shareholders

Major Shareholders Latest
Shareholder
RA Capital Management, L.P.
8.45%1.92M0.05%+0
Adage Capital Management, L.P.
6.71%1.52M1.31%-285.00K
BlackRock, Inc.
6.26%1.42M5.17%+1.17M
The Goldman Sachs Group, Inc.
6.12%1.39M<0.01%+0
Vanguard Capital Management, LLC
4.87%1.10M1.08%+249.70K
Acorn Bioventures
4.50%1.02M2.19%-496.45K
Catalio Capital Management, LP
4.15%940.86K0.17%+43.15K
Avidity Partners Management, L.P.
4.08%924.49K2.02%+460.75K
T. Rowe Price Group, Inc.
3.59%813.53K3.30%-739.44K
J. Wood Capital Advisors LLC
3.46%784.80K0.02%+0
Two Sigma Investments, LP
3.07%695.26K2.39%+544.03K
Kalehua Capital Management LLC
3.02%685.64K--+685.64K
Highbridge Capital Management, LLC
2.87%649.98K0.02%+0
New Enterprise Associates, Inc.
2.54%576.78K--+576.78K
STRS Ohio
2.39%542.50K--+542.50K
Ghisallo Capital Management LLC
2.20%500.00K--+500.00K
Geode Capital Management, LLC
2.02%458.52K0.32%-72.71K
Soleus Capital Management, L.P.
1.94%440.00K0.01%+0
UBS Asset Management AG
1.56%353.55K0.70%+159.53K
State Street Investment Management
1.44%325.99K1.08%+245.25K
© 2026 Longbridge｜Terms of ServicePrivacy Policy